What does TRAVEL PHARMA do?

TRAVEL PHARMA is a pharmacy in Oudenaarde. Private Limited, started on 10 December 2015, 1 establishment.

What is the address of TRAVEL PHARMA?

The registered office of TRAVEL PHARMA is located at Reytstraat 103, 9700 Oudenaarde.

Is TRAVEL PHARMA still active?

Yes. According to the CBE (31 October 2026) TRAVEL PHARMA is active, legal situation “Normale toestand”, started on 10 December 2015.

Is TRAVEL PHARMA registered on Peppol?

Yes, TRAVEL PHARMA is registered on the Peppol network with ID 0208:0644400989.

What is the enterprise number of TRAVEL PHARMA?

The enterprise number of TRAVEL PHARMA is BE0644400989.

When was TRAVEL PHARMA founded?

TRAVEL PHARMA was founded on 10 December 2015.

Who are the directors of TRAVEL PHARMA?

According to the 2025 annual accounts, the directors of TRAVEL PHARMA are: Alexander Schmitt.

Is TRAVEL PHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 December 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did TRAVEL PHARMA make in 2025?

TRAVEL PHARMA posted a profit after taxes of € 30,350 in financial year 2025.

What is the revenue of TRAVEL PHARMA?

As a small company, TRAVEL PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 41,397.

Does TRAVEL PHARMA have a website?

Yes, TRAVEL PHARMA has a website at authority.biz.

TRAVEL PHARMA (Private Limited) - Oudenaarde

Dossier TRAVEL PHARMA, printed on 31 October 2026 from databakkes.be/en/0644400989/travel-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.

Financials

Financial year 2025

TRAVEL PHARMA from Oudenaarde, company number BE0644400989, closed financial year 2025 with a result of € 30,350 after tax. For that financial year TRAVEL PHARMA recorded a gross margin of € 41,397 and equity of € -9,903. Compared with financial year 2024, the result moved from € -11,862 to € 30,350. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 28, 2026.

What it is worth Caution

€ -9,903

▲ € 30,350 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 30,350

▲ still € 11,862 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 185

▲ € 146 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -28,503.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 9,554

▲ 101% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 12,794

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 9,139 Gross margin 2022: € 9,139 First fiscal year in the series	€ -2,974 Gross margin 2023: € -2,974 ▼ € 12,112 vs 2022 (€ 9,139) Unfavourable step	€ -1,984 Gross margin 2024: € -1,984 ▲ € 990 vs 2023 (€ -2,974) Favourable step	€ 41,397 Gross margin 2025: € 41,397 ▲ € 43,381 vs 2024 (€ -1,984) Favourable step	▲ € 43,381
Profit after taxes	€ -948 Profit after taxes 2022: € -948 First fiscal year in the series	€ -11,069 Profit after taxes 2023: € -11,069 ▼ € 10,121 vs 2022 (€ -948) Unfavourable step	€ -11,862 Profit after taxes 2024: € -11,862 ▼ € 794 vs 2023 (€ -11,069) Unfavourable step	€ 30,350 Profit after taxes 2025: € 30,350 ▲ € 42,212 vs 2024 (€ -11,862) Favourable step	▲ € 42,212
Equity	€ -17,322 Equity 2022: € -17,322 First fiscal year in the series	€ -28,391 Equity 2023: € -28,391 ▼ € 11,069 vs 2022 (€ -17,322) Unfavourable step	€ -40,253 Equity 2024: € -40,253 ▼ € 11,862 vs 2023 (€ -28,391) Unfavourable step	€ -9,903 Equity 2025: € -9,903 ▲ € 30,350 vs 2024 (€ -40,253) Favourable step	▲ € 30,350
Total debts	€ 57,914 Total debts 2022: € 57,914 First fiscal year in the series	€ 61,848 Total debts 2023: € 61,848 ▲ 7% vs 2022 (€ 57,914) Unfavourable step	€ 64,545 Total debts 2024: € 64,545 ▲ 4% vs 2023 (€ 61,848) Unfavourable step	€ 100,439 Total debts 2025: € 100,439 ▲ 56% vs 2024 (€ 64,545) Unfavourable step	▲ 56%
Cash	€ 788 Cash 2022: € 788 First fiscal year in the series	€ 4,553 Cash 2023: € 4,553 ▲ € 3,765 vs 2022 (€ 788) Favourable step	€ 39 Cash 2024: € 39 ▼ 99% vs 2023 (€ 4,553) Unfavourable step	€ 185 Cash 2025: € 185 ▲ € 146 vs 2024 (€ 39) Favourable step	▲ € 146
Retained profit	€ -35,922 Retained profit 2022: € -35,922 First fiscal year in the series	€ -46,991 Retained profit 2023: € -46,991 ▼ € 11,069 vs 2022 (€ -35,922) Unfavourable step	€ -58,853 Retained profit 2024: € -58,853 ▼ € 11,862 vs 2023 (€ -46,991) Unfavourable step	€ -28,503 Retained profit 2025: € -28,503 ▲ € 30,350 vs 2024 (€ -58,853) Favourable step	▲ € 30,350
Balance sheet total	€ 40,592 Balance sheet total 2022: € 40,592 First fiscal year in the series	€ 33,457 Balance sheet total 2023: € 33,457 ▼ 18% vs 2022 (€ 40,592) Unchanged	€ 24,292 Balance sheet total 2024: € 24,292 ▼ 27% vs 2023 (€ 33,457) Unchanged	€ 90,536 Balance sheet total 2025: € 90,536 ▲ 273% vs 2024 (€ 24,292) Unchanged	▲ 273%

Key figures of TRAVEL PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to TRAVEL PHARMA?

What happened at TRAVEL PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 28, 2026 New annual accounts for financial year 2025: profit of € 30,350. Source: NBB ↗
2019 Alexander Schmitt became a director. NBB
Dec 10, 2015 New establishment in Oudenaarde. KBO
Dec 10, 2015 Start of the company according to the CBE. KBO

In short

From € 948 loss in 2022 to € 30,350 profit in 2025.

Best year ever: 2025, with € 30,350 profit.

Original PDFs at the National Bank ↗

Management

LEGACY 100%

The stake of LEGACY comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

TRAVEL PHARMA

Behind TRAVEL PHARMA is Alexander Schmitt. The shares are held by LEGACY (100%).

Directors

According to the 2025 annual accounts

Alexander Schmitt

Director

Also active at: LEGACY, AUTHORITY

since 2019

Shareholders

LEGACY

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Reytstraat 103

9700 Oudenaarde

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

LEGACY same network

€ 39,762 gross margin · 2025

AUTHORITY same network

€ 9,955 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS authority.biz

Technologies

Cloudflare CDNCookie ConsentGoogle AnalyticsHubSpot MarketingjQuery

Hosting & Email

Email provider

Microsoft 365

Hosting

CLOUDFLARESPECTRUM Cloudflare, Inc., US

Domain

authority.biz

Registered

2001-11-07

Registrar

Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA

Expires

2026-11-06

Website info

HTTPS Ja

Indexable pages 60

Languages NL

Features

Blog Jobs Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Network

✓ Load balancing

Details

Company number: 0644.400.989
VAT number: BE 0644.400.989
Registered office: Reytstraat 103, 9700 Oudenaarde
Names & denominations: TRAVEL PHARMA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 10 December 2015
Peppol: Active · Active since 8 Dec 2025
Contact: authority.biz
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗